GLOBO Evaluates 100% of Interpreter Sessions with 'Live Quality' AI

Better interpreter quality improves communication between providers and limited-English-speaking patients, lowering re-admissions, hospital stays, and medical errors

PHILADELPHIA, March 11, 2025 /PRNewswire/ -- GLOBO Language Solutions, the leading B2B provider of interpreting and translation services, announces GLOBO Live Quality, an artificial intelligence (AI) monitoring tool used to evaluate 100% of its video and audio interpreting calls. GLOBO is first to market with this novel AI monitoring technology, which helps to ensure a more compliant and professional experience during every encounter.

Although interpreter standards are in place today, monitoring practices vary widely among health systems and language service providers. Interpreter quality evaluations are typically manual with humans reviewing a sampling of sessions to ensure consistent quality and user experiences across the board. Relying on sampling can be especially problematic for large healthcare organizations averaging more than 100,000 minutes or more of video and audio remote interpreting each month. At high volume, humans can only evaluate a small fraction of interactions to identify and reduce language barriers.

The high cost of no or poor interpreting

With more than 68 million people in the United States speaking a language other than English, accurate medical interpretation isn't just a compliance requirement—it's imperative for patient safety, experience, and clinical outcomes. In one study examining readmission rates and the length of hospital stays for limited English proficient (LEP) patients, researchers found that approximately 24% of those who did not have access to an interpreter during admission and discharge were readmitted within 30 days. Additionally, patients who used an interpreter had a significantly shorter stay than LEP patients without an interpreter (2.57 days vs. 5.06 days).

A poor interpreting experience also puts patients at risk, with the National Institutes of Health (NIH) blaming incorrect diagnoses, missed symptoms, wrong medication dosages, inappropriate treatment plans, delayed care, non-compliance with treatment instructions, and even patient harm, all on miscommunication due to language barriers when a qualified interpreter is not used or when the interpretation is inaccurate.

Without adequate language support, LEP patients are less likely to understand their diagnosis, treatment plans, or follow-up care and feel confident about the care they receive. They are also more likely to have negative experiences with their care providers.

According to Jennifer Winters, assistant vice president of Value Based Care at Affinia Healthcare, high-quality interpretation from the start of care is fundamental. "Recognizing the patient's cultural and linguistic needs can create a greater level of understanding, lead to better outcomes, and reduce repeat visits, as it allows healthcare providers to see a more complete picture of the patient's health," she said.

Taking a proactive approach to interpreter quality

GLOBO strives to redefine interpretation excellence with GLOBO Live Quality, quickly assessing anything that might be disruptive during a video or audio interpreting session—from backgrounds and attire to lighting and image clarity. Leveraging AI to monitor and evaluate sessions helps healthcare partners:

• Gain a better understanding of interpretation quality across all encounters
• Address issues before they impact patient care
• Improve patient understanding and confidence
• Enhance patient-provider experience and satisfaction

"We are thrilled to be the first in the language services industry leveraging AI to ensure all interpreter sessions are reviewed," said Elizabeth Robeck, GLOBO senior vice president of Operations. "This is a real game-changer for providing greater insight into the quality of each interaction and delivering consistent experiences for patients and providers."

Having the capability to evaluate every interaction also puts the language solutions industry one step closer to better defining measurable standards for assessing the quality of each medical interpretation session. In this spirit, GLOBO Live Quality is more than just an improvement in language services; it's a crucial step closer to ensuring safer, more effective care for all patients, no matter what language they speak.

About GLOBO
GLOBO Language Solutions ("GLOBO") is ranked No. 6 in Nimdzi's 2024 top 10 U.S. healthcare interpreting companies facilitating effective patient communication between healthcare providers and LEP patients. The company manages an independent global network of more than 8,000 linguists who speak 430+ languages and dialects. GLOBO supports leading healthcare organizations across the country through on-demand audio, video, on-site, and sign language interpreting; actionable insights; and translation of documents, emails, texts, and chats in a single AI-powered platform. GLOBO has been listed on the Inc. 500|5000 eight times. In 2024 GLOBO was named a 2024 Vendors Division Semi-Finalist in Healthcare Innovation Magazine's annual Innovator Awards Program and designated a Deloitte Technology Fast 500™ winner, putting them among the top growth companies in North America. Become a fan of GLOBO on Facebook, follow us on X, LinkedIn, and Instagram.

GLOBO Media Contact:
Angela Jenkins  
Angela Jenkins & Associates, LLC for GLOBO 
303.877.0115 (MT)
[email protected] 

SOURCE GLOBO Language Solutions, LLC